13F

Stock

CASI Pharmaceuticals, Inc.

CASIF · held by 16 managers

Reported value

$1.06M

Holders

16

+0 new · −0 exited

Holders’ est. mark

−$16.4K

Price effect on 2 books still in the name

Largest holder

$839.2K

VR ADVISER, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
VR ADVISER, LLC987.3K$839.2KHeld
Woodline Partners LP133.4K$113.4KHeld
Renaissance Technologies43.1K$36.6KHeld
TWO SIGMA INVESTMENTS, LP23.8K$20.2KHeld
BANK OF AMERICA CORP /DE/19.9K$16.9K−$16.1KCut−$406.2K
GEODE CAPITAL MANAGEMENT, LLC18.8K$16KHeld
Citadel14K$11.9KHeld
ROYAL BANK OF CANADA9.95K$8KHeld
UBS Group AG659$560Held
WELLS FARGO & COMPANY/MN505$429Held
MORGAN STANLEY367$312−$296Cut−$294
BNP PARIBAS FINANCIAL MARKETS134$114Held
SIMPLEX TRADING, LLC133$113Held
JPMORGAN CHASE & CO25$21Held
Colonial Trust Co / SC11$9Held
MAI Capital Management5$5Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.